BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10783369)

  • 21. Outcome of chromosomally normal livebirths with increased fetal nuchal translucency at 10-14 weeks' gestation.
    Brady AF; Pandya PP; Yuksel B; Greenough A; Patton MA; Nicolaides KH
    J Med Genet; 1998 Mar; 35(3):222-4. PubMed ID: 9541107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormalities of the heart and great arteries in chromosomally normal fetuses with increased nuchal translucency thickness at 11-13 weeks of gestation.
    Hyett J; Moscoso G; Papapanagiotou G; Perdu M; Nicolaides KH
    Ultrasound Obstet Gynecol; 1996 Apr; 7(4):245-50. PubMed ID: 8726875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alterations of the fetal extracellular matrix in the nuchal oedema of Down's syndrome.
    Brand-Saberi B; Flöel H; Christ B; Schulte-Vallentin M; Schindler H
    Ann Anat; 1994 Dec; 176(6):539-47. PubMed ID: 7832286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maternal serum pregnancy-associated plasma protein A and fetal nuchal translucency thickness for the prediction of fetal trisomies in early pregnancy.
    Brizot ML; Snijders RJ; Bersinger NA; Kuhn P; Nicolaides KH
    Obstet Gynecol; 1994 Dec; 84(6):918-22. PubMed ID: 7526305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First-trimester nuchal translucency measurement and echocardiography at 16 to 18 weeks of gestation in prenatal detection for trisomy 18.
    Cheng PJ; Liu CM; Chueh HY; Lin CM; Soong YK
    Prenat Diagn; 2003 Mar; 23(3):248-51. PubMed ID: 12627429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The anatomy of nuchal translucency at 10-14 weeks gestation in fetuses with trisomy 21: An incredible medical mystery.
    Nafziger E; Vilensky JA
    Clin Anat; 2014 Apr; 27(3):353-9. PubMed ID: 24488865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy.
    Nicolaides KH; Azar G; Byrne D; Mansur C; Marks K
    BMJ; 1992 Apr; 304(6831):867-9. PubMed ID: 1392745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Results of cytogenetic examinations in fetuses with increased nuchal translucency].
    Kornacki J; Ziółkowska K; Goździewicz T; Skrzypczak J
    Ginekol Pol; 2012 Mar; 83(3):189-93. PubMed ID: 22568194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distribution of extracellular matrix components in nuchal skin from fetuses carrying trisomy 18 and trisomy 21.
    Brand-Saberi B; Epperlein HH; Romanos GE; Christ B
    Cell Tissue Res; 1994 Sep; 277(3):465-75. PubMed ID: 7954686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First trimester diagnosis of fetal nuchal edema. Report of 29 cases.
    Brun JL; Saura R; Horovitz J; Maugey B; Taine L; Roux D; Vergnaud A
    Fetal Diagn Ther; 1994; 9(4):246-51. PubMed ID: 7945905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Study on several ultrasound markers combined maternal serum biochemical markers to screen fetal chromosomal aneuploidy at 11 to 13(+)6 weeks of gestation].
    Chen X; Chang Y; Cui HY; Ren CC; Yu BY
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):815-8. PubMed ID: 24444556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac malformations in first-trimester fetuses with increased nuchal translucency: ultrasound diagnosis and postmortem morphology.
    Haak MC; Bartelings MM; Gittenberger-De Groot AC; Van Vugt JM
    Ultrasound Obstet Gynecol; 2002 Jul; 20(1):14-21. PubMed ID: 12100412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: relationship with nuchal translucency measurement and fetal outcome.
    Bilardo CM; Müller MA; Zikulnig L; Schipper M; Hecher K
    Ultrasound Obstet Gynecol; 2001 Apr; 17(4):288-94. PubMed ID: 11339183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significance of cardiovascular malformations in cystic hygroma: a new interpretation of the pathogenesis.
    Miyabara S; Sugihara H; Maehara N; Shouno H; Tasaki H; Yoshida K; Saito N; Kayama F; Ibara S; Suzumori K
    Am J Med Genet; 1989 Dec; 34(4):489-501. PubMed ID: 2533851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10-14 weeks of gestation.
    Souka AP; Snijders RJ; Novakov A; Soares W; Nicolaides KH
    Ultrasound Obstet Gynecol; 1998 Jun; 11(6):391-400. PubMed ID: 9674084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First-trimester screening for trisomies 18 and 13, triploidy and Turner syndrome by detailed early anomaly scan.
    Wagner P; Sonek J; Hoopmann M; Abele H; Kagan KO
    Ultrasound Obstet Gynecol; 2016 Oct; 48(4):446-451. PubMed ID: 26611869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for chromosomal abnormalities in an unselected population by fetal nuchal translucency.
    Hafner E; Schuchter K; Philipp K
    Ultrasound Obstet Gynecol; 1995 Nov; 6(5):330-3. PubMed ID: 8590203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unfused amnion and chorion after 14 weeks of gestation: associated fetal structural and chromosomal abnormalities.
    Ulm B; Ulm MR; Bernaschek G
    Ultrasound Obstet Gynecol; 1999 Jun; 13(6):392-5. PubMed ID: 10423801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrauterine lethality of trisomy 21 fetuses with increased nuchal translucency thickness.
    Hyett JA; Sebire NJ; Snijders RJ; Nicolaides KH
    Ultrasound Obstet Gynecol; 1996 Feb; 7(2):101-3. PubMed ID: 8776233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of risk for chromosomal abnormalities at 10-14 weeks of gestation by nuchal translucency and maternal age in 5,210 fetuses at a single centre.
    Zoppi MA; Ibba RM; Putzolu M; Floris M; Monni G
    Fetal Diagn Ther; 2000; 15(3):170-3. PubMed ID: 10782003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.